US Patent Issued to Neurocrine Biosciences on July 21 for "Substituted pyrazolo[1,5-Alphapyrimidines as CRF receptor antagonists" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,680, issued on July 21, was assigned to Neurocrine Biosciences Inc. (San Diego).

"Substituted pyrazolo[1,5-Alphapyrimidines as CRF receptor antagonists" was invented by Neil J. Ashweek (San Diego), John P. Williams (San Diego), Lev Alexander Zegelman (San Diego), Christina Marie Costa (San Diego), Scott Stirn (San Diego), Shawn Branum (San Diego), Jackie Le (San Diego), John Lloyd Tucker (San Diego), Brian M. Cochran (San Diego), David Kucera (San Diego), Donald Hettinger (San Diego) and Max A. Mellmer (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds are provided herein that antagonize corticotropin-releasing factor (CRF) receptor...